ArticleBMC medicine2026

Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.

Martin B Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.